Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ronald Kirk Huntsman currently holds 364,755 shares of Vivos Therapeutics, Inc. (VVOS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ronald Kirk Huntsman has been a net buyer of VVOS stock. They have purchased $116.3K and sold $0 worth of shares.
Ronald Kirk Huntsman's most recent insider trade was on Nov 26, 2024, when they sold 315,421 shares at $2.64 per share.
Ronald Kirk Huntsman serves as Executive at Vivos Therapeutics, Inc. (VVOS). They have executed 14 insider transactions totaling $116.3K over their tenure at the company.
Ronald Kirk Huntsman holds the position of Executive at Vivos Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Ronald Kirk Huntsman has shown a buying trading pattern, with $116.3K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Ronald Kirk Huntsman was on Nov 26, 2024, when they purchased $832.7K worth of VVOS shares. This transaction involved 315,421 shares at $2.64 per share.
Ronald Kirk Huntsman currently owns 364,755 shares of Vivos Therapeutics, Inc. (VVOS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ronald Kirk Huntsman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ronald Kirk Huntsman has 14 Form 4 filings on record as an insider at Vivos Therapeutics, Inc..
Set alerts for Ronald Kirk Huntsman and 40,000+ other insiders.